References
- Allerberger, F., D. Rossboth, M. P. Dierich, S. Aleksic, H. Schmidt, and H. Karch. 1996. Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children. Eur. J. Clin. Microbiol. Infect. Dis. 15: 545-550 https://doi.org/10.1007/BF01709361
- Cordovez, A., V. Prado, L. Maggi, J. Cordero, J. Martinez, A. Misraji, et al. 1992. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J. Clin. Microbiol. 30: 2153-2157
- Clinical and Laboratory Standards Institute (CLSI). 2008. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved Standard 3rd Ed. CLSI document M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA
- Griffin, P. M. and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohaemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13: 60-98
- Herold, S., J. Siebert, A. Huber, and H. Schmidt. 2005. Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin. Antimicrob. Agents Chemother. 49: 931-944 https://doi.org/10.1128/AAC.49.3.931-944.2005
-
Holland, R. E., R. A. Wilson, M. S. Holland, V. Yuzbasiyan-Gurkan, T. P. Mullaney, and D. G. White. 1999. Characterization of
$eae^+$ Escherichia coli isolated from healthy and diarrheic calves. Vet. Microbiol. 66:251-263 https://doi.org/10.1016/S0378-1135(99)00013-9 - Jeon, B., J. Jeong, G. Won, H. Park, S. Eo, H. Kang, J. Hur, and J. H. Lee. 2006. Prevalence and characteristics of Escherichia coli O26 and O111 from cattle in Korea. Int. J. Food Microbiol. 110: 123-126 https://doi.org/10.1016/j.ijfoodmicro.2006.01.035
- Jo, M., J. Kim, J. Lim, M. Kang, H. Koh, Y. Park, et al. 2004. Prevalence and characteristics of Escherichia coli O157 from major food animals in Korea. Int. J. Food Microbiol. 95: 41-49 https://doi.org/10.1016/j.ijfoodmicro.2004.01.016
- Laegreid, W. W., R. O. Elder, and J. E. Keen. 1999. Prevalence of Escherichia coli O157:H7 in range beef calves at weaning. Epidemiol. Infect. 123: 291-298 https://doi.org/10.1017/S0950268899002757
- Murakami, J., K. Kishi, K. Hirai, K. Hiramatsu, T. Yamasaki, and M. Nasu. 2000. Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro. Int. J. Antimicrob. Agents 15: 103-109 https://doi.org/10.1016/S0924-8579(00)00126-6
- Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160: 994-999 https://doi.org/10.1093/infdis/160.6.994
- Pavia, A. T., C. R. Nichols, and P. A. Blake. 1992. Hemolyticuremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons:Clinical and epidemiologic observations. J. Pediatr. 116: 544-551 https://doi.org/10.1016/S0022-3476(05)81600-2
- Prins, J. M., S. J. H. van Deventer, E. J. Kuijper, and P. Speelman. 1994. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob. Agents Chemother. 38: 1211-1218 https://doi.org/10.1128/AAC.38.6.1211
- Riley, L.W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, et al. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685 https://doi.org/10.1056/NEJM198303243081203
- Su, C. and L. J. Brandt. 1995. Escherichia coli O157:H7 infection in humans. Ann. Intern. Med. 123: 698-714 https://doi.org/10.7326/0003-4819-123-9-199511010-00009
- Sunde, M., K. Fossum, A. Solberg, and H. Sorum. 1998. Antibiotic resistance in Escherichia coli of the normal intestinal flora of swine. Microb. Drug Resist. 4: 289-299 https://doi.org/10.1089/mdr.1998.4.289
- Walterspiel, J. N., S. Ashkenazi, A. L. Morrow, and T. G. Cleary. 1992. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1. Infection 20: 25-29 https://doi.org/10.1007/BF01704889
- Wong, C. S., S. Jelacic, R. L. Habeeb, S. L. Watkins, and P. I. Tarr. 2000. The risk of hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342: 1930-1936 https://doi.org/10.1056/NEJM200006293422601
- Yoh, M. and T. Honda. 1997. The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Epidemiol. Infect. 119: 101-103 https://doi.org/10.1017/S0950268897007541
- Zhang, X., A. D. McDaniel, L. E. Wolf, G. T. Keusch, M. K. Waldor, and D. W. Acheson. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181: 664-670 https://doi.org/10.1086/315239
Cited by
- Effects of Subinhibitory Concentrations of Antimicrobial Agents onEscherichia coliO157:H7 Shiga Toxin Release and Role of the SOS Response vol.10, pp.9, 2009, https://doi.org/10.1089/fpd.2013.1510
- Versorgung und Behandlung von EHEC/HUS-Patienten : Erfahrungen und Perspektiven aus infektiologischer Sicht vol.56, pp.1, 2013, https://doi.org/10.1007/s00103-012-1577-1